LifePoint Health Company Profile (NASDAQ:LPNT)

About LifePoint Health (NASDAQ:LPNT)

LifePoint Health logoLifePoint Health, Inc., through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities. Its services include general surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, rehabilitation services and pediatric services, and in some of its hospitals, the Company offers specialized services, such as open-heart surgery, skilled nursing, psychiatric care and neuro-surgery. It provides outpatient services, such as same-day surgery, laboratory, x-ray, respiratory therapy, imaging, sports medicine and lithotripsy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Hospitals
  • Sub-Industry: Health Care Facilities
  • Symbol: NASDAQ:LPNT
  • CUSIP: 53219L10
  • Web:
  • Market Cap: $2.52 billion
  • Outstanding Shares: 40,366,000
Average Prices:
  • 50 Day Moving Avg: $62.33
  • 200 Day Moving Avg: $60.59
  • 52 Week Range: $50.60 - $71.00
  • Trailing P/E Ratio: 16.48
  • Foreward P/E Ratio: 13.46
  • P/E Growth: 1.66
Sales & Book Value:
  • Annual Revenue: $6.41 billion
  • Price / Sales: 0.39
  • Book Value: $55.71 per share
  • Price / Book: 1.12
  • EBIDTA: $738.4 million
  • Net Margins: 1.93%
  • Return on Equity: 7.02%
  • Return on Assets: 2.58%
  • Debt-to-Equity Ratio: 1.28%
  • Current Ratio: 1.80%
  • Quick Ratio: 1.61%
  • Average Volume: 384,521 shs.
  • Beta: 0.87
  • Short Ratio: 7.7

Frequently Asked Questions for LifePoint Health (NASDAQ:LPNT)

What is LifePoint Health's stock symbol?

LifePoint Health trades on the NASDAQ under the ticker symbol "LPNT."

How were LifePoint Health's earnings last quarter?

LifePoint Health Inc (NASDAQ:LPNT) posted its quarterly earnings data on Friday, April, 28th. The company reported $1.07 EPS for the quarter, topping analysts' consensus estimates of $1.01 by $0.06. The firm earned $1.63 billion during the quarter, compared to analysts' expectations of $1.64 billion. LifePoint Health had a return on equity of 7.02% and a net margin of 1.93%. The firm's quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the business posted $0.85 EPS. View LifePoint Health's Earnings History.

Where is LifePoint Health's stock going? Where will LifePoint Health's stock price be in 2017?

13 analysts have issued twelve-month target prices for LifePoint Health's shares. Their predictions range from $59.00 to $77.00. On average, they expect LifePoint Health's stock price to reach $64.70 in the next twelve months. View Analyst Ratings for LifePoint Health.

What are analysts saying about LifePoint Health stock?

Here are some recent quotes from research analysts about LifePoint Health stock:

  • 1. According to Zacks Investment Research, "LifePoint Health’s earnings per share of $1.09 outpaced the Zacks Consensus Estimate by 1.9% but dipped 1.8% year over year, due to an anticipated decrease in electronic health record incentive income and higher depreciation and interest expense associated with the company’s recent acquisitions. LifePoint Health faces a number of headwinds with respect to the possibility of Trump repealing ObamaCare, increasing bad debts, expenses rising faster than revenue growth. The company has also underperformed the Zacks categorized Medical Hospital industry. It is, however, well poised to grow over the long term given a number of acquisitions made over the past few years that gives it a strong foothold in the industry. A number of divestures made in recent years have also helped the company focus on growth areas. Its strong balance sheet and consistent increase in operating cash flow enables it to use funds for share buybacks and acquisitions." (2/22/2017)
  • 2. Cantor Fitzgerald analysts commented, "We are reiterating our neutral rating and $55 price target, adjusting our 2017 adjusted EPS estimates and introducing 2018 estimates. Margins continue to be weak, and although we expect them to be relatively stable in 2017-18, our earnings outlook is generally lower than consensus and management's 2017 outlook. In our view, LPNT's acquisition strategy and joint venture have added some promising properties, but they are weighing on earnings as volumes remain disappointing." (2/21/2017)

Who are some of LifePoint Health's key competitors?

Who owns LifePoint Health stock?

LifePoint Health's stock is owned by many different of institutional and retail investors. Top institutional investors include American Century Companies Inc. (9.74%), BlackRock Inc. (9.38%), Dimensional Fund Advisors LP (8.48%), Vanguard Group Inc. (8.18%), Wellington Management Group LLP (8.15%) and Alliancebernstein L.P. (4.32%). Company insiders that own LifePoint Health stock include David M Dill, Gregory T Bier, John E D D S Maupin Jr, John P Bumpus and Richard H Evans. View Institutional Ownership Trends for LifePoint Health.

Who sold LifePoint Health stock? Who is selling LifePoint Health stock?

LifePoint Health's stock was sold by a variety of institutional investors in the last quarter, including American Century Companies Inc., Hotchkis & Wiley Capital Management LLC, Bank of New York Mellon Corp, Nordea Investment Management AB, Nationwide Fund Advisors, Russell Investments Group Ltd., Letko Brosseau & Associates Inc. and Sei Investments Co.. Company insiders that have sold LifePoint Health stock in the last year include David M Dill, John P Bumpus and Richard H Evans. View Insider Buying and Selling for LifePoint Health.

Who bought LifePoint Health stock? Who is buying LifePoint Health stock?

LifePoint Health's stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Point72 Asset Management L.P., LSV Asset Management, Victory Capital Management Inc., Prudential Financial Inc., UBS Asset Management Americas Inc., Goldman Sachs Group Inc. and Wellington Management Group LLP. View Insider Buying and Selling for LifePoint Health.

How do I buy LifePoint Health stock?

Shares of LifePoint Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of LifePoint Health stock cost?

One share of LifePoint Health stock can currently be purchased for approximately $62.45.

Analyst Ratings

Consensus Ratings for LifePoint Health (NASDAQ:LPNT) (?)
Ratings Breakdown: 2 Sell Ratings, 8 Hold Ratings, 3 Buy Ratings
Consensus Rating:Hold (Score: 2.08)
Consensus Price Target: $64.70 (3.60% upside)

Analysts' Ratings History for LifePoint Health (NASDAQ:LPNT)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/1/2017Barclays PLCBoost Price TargetEqual Weight$58.00 -> $60.00LowView Rating Details
4/4/2017Deutsche Bank AGInitiated CoverageHold -> Hold$68.00LowView Rating Details
3/27/2017MizuhoBoost Price TargetNeutral -> Neutral$57.00 -> $62.00MediumView Rating Details
2/21/2017Cantor FitzgeraldReiterated RatingNeutralN/AView Rating Details
1/4/2017Piper Jaffray CompaniesInitiated CoverageNeutral$62.00N/AView Rating Details
11/11/2016Credit Suisse Group AGDowngradeOutperform -> Neutral$70.00 -> $60.00N/AView Rating Details
11/9/2016Avondale PartnersDowngradeOutperform -> Market PerformN/AView Rating Details
11/9/2016Bank of America CorpDowngradeNeutral -> Underperform$66.00 -> $59.00N/AView Rating Details
10/25/2016Wolfe ResearchInitiated CoverageUnderperformN/AView Rating Details
9/30/2016Citigroup IncReiterated RatingBuy$68.00N/AView Rating Details
8/2/2016Raymond James Financial, Inc.Lower Price TargetOutperform$75.00 -> $65.00N/AView Rating Details
8/1/2016Royal Bank of CanadaReiterated RatingOutperform$84.00 -> $77.00N/AView Rating Details
8/1/2016WedbushReiterated RatingNeutral$80.00 -> $66.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
5/16/2016Robert W. BairdReiterated RatingBuyN/AView Rating Details
5/2/2016Leerink SwannReiterated RatingHoldN/AView Rating Details
2/19/2016Goldman Sachs Group IncLower Price TargetNeutral$81.00 -> $77.00N/AView Rating Details
2/16/2016SunTrust Banks, Inc.Lower Price TargetNeutral$80.00 -> $72.00N/AView Rating Details
11/2/2015Oppenheimer Holdings Inc.Reiterated RatingMarket PerformN/AView Rating Details
11/2/2015BMO Capital MarketsLower Price Target$81.00 -> $74.00N/AView Rating Details
10/19/2015Susquehanna Bancshares IncLower Price TargetNeutral$85.00 -> $75.00N/AView Rating Details
9/16/2015JPMorgan Chase & Co.Initiated CoverageNeutral$79.00N/AView Rating Details
(Data available from 5/27/2015 forward)


Earnings History for LifePoint Health (NASDAQ:LPNT)
Earnings by Quarter for LifePoint Health (NASDAQ:LPNT)
Earnings History by Quarter for LifePoint Health (NASDAQ:LPNT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/28/2017Q1 2017$1.01$1.07$1.64 billion$1.63 billionViewN/AView Earnings Details
2/17/2017Q4 2016$1.07$1.09$1.63 billion$1.61 billionViewN/AView Earnings Details
10/28/2016Q316$0.84$0.94$1.59 billion$1.59 billionViewListenView Earnings Details
7/29/2016Q216$0.90$0.71$1.61 billion$1.59 billionViewListenView Earnings Details
4/29/2016Q1$0.88$0.87$1.57 billion$1.58 billionViewListenView Earnings Details
2/12/2016Q415$1.06$1.11$1.39 billion$1.37 billionViewListenView Earnings Details
10/30/2015Q315$0.90$0.94$1.30 billion$1.31 billionViewListenView Earnings Details
7/31/2015Q215$0.98$1.00$1.24 billion$1.27 billionViewListenView Earnings Details
5/1/2015Q115$1.00$1.00$1.24 billion$1.26 billionViewListenView Earnings Details
2/12/2015Q414$1.01$1.08$1.25 billion$1.26 billionViewListenView Earnings Details
10/24/2014Q314$0.74$0.75$1.09 billion$1.38 billionViewListenView Earnings Details
7/25/2014Q214$0.55$0.84$1.01 billion$1.05 billionViewListenView Earnings Details
4/25/2014Q114$0.65$0.65$1,000.00 million$1.01 billionViewListenView Earnings Details
2/14/2014Q413$0.80$0.75$952.10 million$952.60 millionViewListenView Earnings Details
10/25/2013Q313$0.66$0.68$891.30 million$899.70 millionViewListenView Earnings Details
7/26/2013Q2 2013$0.72$0.65$911.08 million$894.90 millionViewListenView Earnings Details
4/26/2013Q1 2013$0.81$0.69$924.00 million$931.10 millionViewListenView Earnings Details
2/15/2013Q4 2012$0.65$0.76$863.49 million$893.30 millionViewListenView Earnings Details
10/26/2012Q312$0.76$0.39$814.52 million$820.20 millionViewN/AView Earnings Details
7/27/2012$0.80$0.83ViewN/AView Earnings Details
4/27/2012$0.91$0.94ViewN/AView Earnings Details
10/28/2011$0.71$0.77ViewN/AView Earnings Details
7/29/2011$0.75$0.77ViewN/AView Earnings Details
4/29/2011$0.81$0.89ViewN/AView Earnings Details
2/18/2011$0.67$0.70ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for LifePoint Health (NASDAQ:LPNT)
2017 EPS Consensus Estimate: $4.17
2018 EPS Consensus Estimate: $4.71
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175$0.89$1.02$0.96
Q2 20175$0.91$0.98$0.95
Q3 20175$0.98$1.06$1.03
Q4 20175$1.19$1.26$1.23
Q1 20182$1.12$1.17$1.15
Q2 20182$1.02$1.08$1.05
Q3 20182$1.13$1.19$1.16
Q4 20182$1.33$1.37$1.35
(Data provided by Zacks Investment Research)


Dividend History for LifePoint Health (NASDAQ:LPNT)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for LifePoint Health (NASDAQ:LPNT)
Insider Ownership Percentage: 7.28%
Institutional Ownership Percentage: 99.88%
Insider Trades by Quarter for LifePoint Health (NASDAQ:LPNT)
Institutional Ownership by Quarter for LifePoint Health (NASDAQ:LPNT)
Insider Trades by Quarter for LifePoint Health (NASDAQ:LPNT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/11/2017Richard H EvansDirectorSell2,000$62.88$125,760.00View SEC Filing  
3/30/2017John P BumpusEVPSell33,333$65.00$2,166,645.00View SEC Filing  
3/16/2017David M DillInsiderSell18,800$62.22$1,169,736.00View SEC Filing  
3/10/2017David M DillInsiderSell1,200$65.00$78,000.00View SEC Filing  
3/9/2017John P BumpusEVPSell26,362$65.05$1,714,848.10View SEC Filing  
3/6/2017John P BumpusEVPSell305$65.00$19,825.00View SEC Filing  
5/25/2016John E D D S Maupin JrDirectorSell3,800$67.32$255,816.00View SEC Filing  
2/18/2016Gregory T BierDirectorSell2,149$63.00$135,387.00View SEC Filing  
5/7/2015Owen G Shell JrDirectorSell7,500$70.69$530,175.00View SEC Filing  
3/9/2015John E D D S Maupin JrDirectorSell1,300$72.50$94,250.00View SEC Filing  
2/23/2015Michael S CogginSVPSell5,000$70.50$352,500.00View SEC Filing  
9/9/2014Marguerite KondrackeDirectorSell1,500$72.43$108,645.00View SEC Filing  
7/31/2014Leif M MurphyCFOSell100,000$72.03$7,203,000.00View SEC Filing  
6/12/2014Richard H EvansDirectorSell1,000$64.05$64,050.00View SEC Filing  
5/16/2014William Carpenter IIICEOSell280,849$58.11$16,320,135.39View SEC Filing  
5/13/2014Paul GilbertEVPSell54,342$59.21$3,217,589.82View SEC Filing  
5/7/2014John BumpusEVPSell20,000$57.20$1,144,000.00View SEC Filing  
3/12/2014Marguerite KondrackeDirectorSell2,000$51.49$102,980.00View SEC Filing  
12/5/2013Paul GilbertEVPSell12,825$51.12$655,614.00View SEC Filing  
10/31/2013Michael S CogginSVPSell2,000$51.14$102,280.00View SEC Filing  
10/30/2013William F Carpenter IIICEOSell40,000$51.31$2,052,400.00View SEC Filing  
8/1/2013Michael CogginSVPSell2,452$50.00$122,600.00View SEC Filing  
6/6/2013Paul D GilbertEVPSell16,667$51.01$850,183.67View SEC Filing  
5/20/2013Richard H EvansDirectorSell4,275$47.50$203,062.50View SEC Filing  
2/25/2013Michael S CogginSVPSell6,668$44.03$293,592.04View SEC Filing  
2/25/2013Richard H EvansDirectorSell5,000$43.31$216,550.00View SEC Filing  
9/14/2012Marguerite SalleeDirectorSell3,000$42.36$127,080.00View SEC Filing  
8/21/2012Michael S CogginSVPSell6,666$41.00$273,306.00View SEC Filing  
8/21/2012William F Carpenter IIICEOSell50,000$41.02$2,051,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for LifePoint Health (NASDAQ:LPNT)
Latest Headlines for LifePoint Health (NASDAQ:LPNT)
DateHeadline logoLifePoint Health, Inc. breached its 50 day moving average in a Bullish Manner : LPNT-US : May 26, 2017 - May 26 at 7:10 PM logoLifePoint Health (LPNT) Presents At UBS Global Healthcare Conference - Slideshow - May 26 at 3:20 AM logoHouse Health Plan Would Boost Uninsured by 23 Million by 2026, CBO Says - May 24 at 6:23 PM logoMeadowview Regional Medical Center Named Duke LifePoint Quality Affiliate - May 22 at 10:18 AM logoLifePoint Hospitals (LPNT) Bank of America Merrill Lynch 2017 Health Care Conference - Slideshow - May 19 at 6:04 PM logoLifePoint Health to Participate In UBS Global Healthcare Conference - May 17 at 6:19 PM logoRichard H. Evans Sells 2,000 Shares of LifePoint Health Inc (LPNT) Stock - May 12 at 10:51 PM logoFY2017 EPS Estimates for LifePoint Health Inc Increased by Analyst (LPNT) - May 11 at 11:12 AM logoLifePoint Health Inc (LPNT) Receives Average Rating of "Hold" from Analysts - May 8 at 11:46 AM logoTrumpcare Gets House Support: What Next? - May 5 at 7:49 AM logoHospital stocks care more about earnings than Trumpcare - May 4 at 6:28 PM logoETFs with exposure to LifePoint Health, Inc. : May 4, 2017 - May 4 at 6:28 PM logoFY2017 Earnings Estimate for LifePoint Health Inc Issued By KeyCorp (LPNT) - May 4 at 3:04 PM logoQ2 2017 Earnings Forecast for LifePoint Health Inc Issued By Leerink Swann (LPNT) - May 4 at 12:32 PM logoLifePoint Health (LPNT) Getting Very Positive Press Coverage, Report Shows - May 4 at 8:50 AM logo$0.91 EPS Expected for LifePoint Health Inc (LPNT) This Quarter - May 4 at 8:40 AM logoLifePoint Health, Inc. breached its 50 day moving average in a Bullish Manner : LPNT-US : May 3, 2017 - May 3 at 5:27 PM logoLifePoint Health, Inc. :LPNT-US: Earnings Analysis: Q1, 2017 By the Numbers : May 3, 2017 - May 3 at 5:27 PM logoFY2017 EPS Estimates for LifePoint Health Inc Lifted by Analyst (LPNT) - May 3 at 1:11 PM logoLifePoint Health Inc (LPNT) to Post Q2 2017 Earnings of $0.96 Per Share, KeyCorp Forecasts - May 3 at 8:02 AM logoLifePoint Health to Participate in Bank of America Merrill Lynch 2017 Health Care Conference - May 2 at 2:55 PM logoBarclays PLC Reiterates "Equal Weight" Rating for LifePoint Health Inc (LPNT) - May 1 at 4:12 PM logoLifePoint Health (LPNT) Earning Favorable Press Coverage, AlphaOne Reports - May 1 at 2:10 PM logoEdited Transcript of LPNT earnings conference call or presentation 28-Apr-17 2:00pm GMT - April 29 at 8:50 AM logoLifePoint Health Inc (LPNT) Releases Earnings Results, Beats Estimates By $0.06 EPS - April 29 at 1:27 AM logoInvestor Network: LifePoint Health, Inc. to Host Earnings Call - April 28 at 7:17 PM logoLifePoint Health (LPNT) Receives Daily Media Impact Score of 0.52 - April 28 at 11:46 AM logoLifePoint Health Q1 Profit Rises - Quick Facts - April 28 at 9:29 AM logoLifePoint Health Reports First Quarter 2017 Results - April 28 at 9:29 AM logoLifePoint beats 1Q profit forecasts - April 28 at 9:29 AM logo7 Top Household Expenses That Are About to Surge, and Those Companies That Could Profit - April 23 at 10:04 AM logoLifePoint Health (LPNT) Getting Very Favorable Media Coverage, Study Finds - April 22 at 7:47 AM logoLifePoint Health, Inc. – Value Analysis (NASDAQ:LPNT) : April 20, 2017 - April 20 at 6:25 PM logoLifePoint Health, Inc. breached its 50 day moving average in a Bearish Manner : LPNT-US : April 19, 2017 - April 19 at 10:47 AM logoVery Favorable News Coverage Very Likely to Affect LifePoint Health (LPNT) Share Price - April 19 at 10:26 AM logo$1.64 Billion in Sales Expected for LifePoint Health Inc (LPNT) This Quarter - April 15 at 9:33 AM logoLifePoint Health (LPNT) Given Media Impact Score of 0.56 - April 15 at 9:00 AM logoLifePoint Health To Broadcast Its First Quarter 2017 Conference Call Live On The Internet - April 13 at 6:02 PM logo$1.03 EPS Expected for LifePoint Health Inc (LPNT) This Quarter - April 13 at 8:14 AM logoLifePoint Health Inc (LPNT) Receives Consensus Rating of "Hold" from Analysts - April 11 at 10:05 AM logoHospital stocks fall after talk of health bill revival - April 7 at 10:59 AM logoLifePoint Health Inc (LPNT) Expected to Post Q1 2018 Earnings of $1.17 Per Share - April 6 at 5:15 PM logoLifePoint Health Inc (LPNT) Receives New Coverage from Analysts at Deutsche Bank AG - April 4 at 5:33 PM logoJohn P. Bumpus Sells 33,333 Shares of LifePoint Health Inc (LPNT) Stock - April 3 at 7:55 PM logoLifePoint Health Inc (LPNT) Price Target Increased to $62.00 by Analysts at Mizuho - March 31 at 12:30 PM logoHow These Healthcare Stocks are Faring? -- GlaxoSmithKline, Universal Health Services, Shire, and LifePoint Health - March 31 at 9:52 AM logoMizuho Increases LifePoint Health Inc (LPNT) Price Target to $62.00 - March 27 at 8:22 PM logoLifePoint Grows Inorganically Yet Stock Suffers: Here's Why - March 27 at 5:52 PM logoLifePoint Health Inc (LPNT) Earns "Neutral" Rating from Cantor Fitzgerald - March 26 at 12:30 PM logoIs Lifepoint Health a Suitable Stock for Value Investors? - Nasdaq - March 24 at 11:24 PM



LifePoint Health (LPNT) Chart for Saturday, May, 27, 2017

This page was last updated on 5/27/2017 by Staff